Ching-Yin Huang

Toshiaki Nakano3
Shigeru Goto3
3Toshiaki Nakano
3Shigeru Goto
3King-Wah Chiu
3Kuang-Den Chen
Learn More
  • King-Wah Chiu, Toshiaki Nakano, Kuang-Den Chen, Chia-Yun Lai, Li-Wen Hsu, Ho-Ching Chiu +4 others
  • 2013
This study used pyrosequencing to determine the proportional distribution of CYP3A5*3 genotypes to further confirm the homogeneous phenomenon that is observed when recipients and donors in living donor liver transplantation (LDLT) have a different single nucleotide polymorphism (SNP) genotype. We enrolled 42 recipient/living donor pairs and the SNPs of(More)
OBJECTIVE Hepatocellular carcinoma (HCC) and its recurrence are major problems in living donor liver transplantation (LDLT). Several biomarkers have been used to investigate this event. We conducted a prospective controlled study to determine the activities of the basic fibroblast growth factor (FGF-2), survivin, Ki67, endostatin, and vascular endothelial(More)
Cytochrome P450 metabolizes many drugs in the liver. Three genotypes of CYP2C19 with extensive, intermediate, and poor metabolizing activity, respectively, have been identified in peripheral blood of transplant recipients and new liver grafts in living donor liver transplantation (LDLT). The expression of the final genotype in liver graft biopsies depends(More)
  • 1